|
Heart failure (N=131) |
No heart failure (N=392) |
Age (years) |
68 (9.4) |
68.4 (9.1) |
Male sex |
95 (72.5) |
301 (76.8) |
Prior MI |
47 (35.9) |
51 (13.0) |
Hypertension |
104 (79.4) |
287 (73.2) |
Diabetes |
55 (42.0) |
106 (27.0) |
Sleep apnea |
19 (14.5) |
44 (11.2) |
Body-mass index |
29.1 (5.6) |
28.7 (5.1) |
Pre-operative medical therapy |
|
|
Beta blocker |
98 (74.8) |
209 (53.3) |
ACE or ARB |
73 (55.7) |
196 (50.0) |
Calcium channel blocker |
26 (19.9) |
84 (21.4) |
Preoperative LVEF (%) |
45.1 (13.3) |
60.3 (5.6) |
Procedure |
|
|
CABG |
65 (49.6) |
147 (37.5) |
Valve repair |
15 (11.5) |
67 (17.1) |
CABG + valve repair |
6 (4.6) |
11 (2.8) |
Valve replacement |
20 (15.2) |
106 (27.0) |
CABG + valve replacement |
25 (19.1) |
61 (15.6) |
CABG only (%) |
65 (49.6) |
147 (37.5) |
Cardiopulmonary bypass time |
122.2 (50.0) |
99.3 (40.0) |
Rhythm control strategy |
64 (48.9) |
197 (50.3) |
Cross-over to alternate strategy (%) |
37 (28.2) |
95 (24.2) |
ICU length of stay (days) |
3.9 (5.5) |
2.6 (3.8) |
Readmission |
30 (22.9) |
96 (24.5) |
Death |
2 (1.5) |
3 (0.8) |
Days alive and out of hospital (days) |
51.0 (12.0) |
52.1 (13.2) |
Sinus rhythm at 7 days |
104 (82.5) |
318 (83.9) |
Sinus rhythm at 30 days |
114 (93.4) |
348 (94.2) |
Sinus rhythm at 60 days |
112 (94.1) |
348 (96.9) |
AF for less than 48 hours |
75 (57.3) |
231 (58.9) |
|
Heart failure (N=131) |
Rate control |
Rhythm control |
Age (years) |
68.0 (11.05) |
67.9 (7.3) |
Male sex |
52 (77.6) |
43 (67.2) |
Prior MI |
26 (38.8) |
21 (32.8) |
Hypertension |
53 (79.1) |
51 (79.7) |
Diabetes |
28 (41.8) |
27 (42.2) |
Sleep apnea |
10 (14.9) |
9 (14.1) |
Body-mass index |
29.2 (5.3) |
29.1 (5.9) |
Pre-operative medical therapy |
|
|
Beta blocker |
52 (77.6) |
46 (71.9) |
ACE or ARB |
37 (55.2) |
36 (56.3) |
Calcium channel blocker |
10 (14.9) |
16 (25.0) |
Preoperative LVEF (%) |
44.3 (13.9) |
46.0 (12.6) |
Procedure |
|
|
CABG |
36 (53.7) |
29 (45.3) |
Valve repair |
8 (11.9) |
7 (10.9) |
CABG + valve repair |
5 (7.5) |
1 (1.6) |
Valve replacement |
9 (13.4) |
11 (17.2) |
CABG + valve replacement |
9 (13.4) |
16 (25.0) |
CABG only (%) |
36 (53.7) |
29 (45.3) |
Cardiopulmonary bypass time |
122.5 (50.4) |
121.9 (50.0) |
Off-pump procedure |
3 (4.5) |
4 (6.3) |
Cross-over to alternate strategy (%) |
17 (25.4) |
20 (31.3) |
Readmission |
16 (23.9) |
14 (21.9) |
Death |
1 (1.5) |
1 (1.6) |
Days alive and out of hospital (days) |
51.1 (11.4) |
50.8 (12.7) |
Sinus rhythm at 7 days |
50 (76.9) |
54 (88.5) |
Sinus rhythm at 30 days |
57 (91.9) |
57 (95.0) |
Sinus rhythm at 60 days |
56 (90.3) |
56 (98.3) |
AF for less than 48 hours |
31 (46.3) |
44 (68.8) |
|
No heart failure (N=392) |
Rate control |
Rhythm control |
Age (years) |
68.9 (9.4) |
67.9 (8.8) |
Male sex |
145 (74.4) |
156 (79.2) |
Prior MI |
24 (12.3) |
27 (13.7) |
Hypertension |
140 (71.8) |
147 (74.6) |
Diabetes |
54 (27.7) |
52 (26.4) |
Sleep apnea |
23 (11.8) |
21 (10.7) |
Body-mass index |
28.1 (4.8) |
29.2 (5.4) |
Pre-operative medical therapy |
|
|
Beta blocker |
110 (56.4) |
99 (50.3) |
ACE or ARB |
102 (52.3) |
94 (47.7) |
Calcium channel blocker |
42 (21.5) |
42 (21.3) |
Preoperative LVEF (%) |
61.0 (6.04) |
59.6 (5.06) |
Procedure |
|
|
CABG |
76 (39.0) |
71 (36.0) |
Valve repair |
31 (15.9) |
36 (18.3) |
CABG + valve repair |
5 (2.6) |
6 (3.1) |
Valve replacement |
51 (26.2) |
55 (27.9) |
CABG + valve replacement |
32 (16.4) |
29 (14.7) |
CABG only (%) |
76 (39.0) |
71 (36.0) |
Cardiopulmonary bypass time |
97.6 (39.9) |
101.04 (40.1) |
Off-pump procedure |
3 (1.5) |
8 (4.1) |
Cross-over to alternate strategy (%) |
53 (27.2) |
42 (21.3) |
Readmission |
46 (23.6) |
50 (25.4) |
Death |
2 (1.03) |
1 (0.5) |
Days alive and out of hospital (days) |
51.3 (13.0) |
52.8 (13.4) |
Sinus rhythm at 7 days |
153 (80.5) |
165 (87.3) |
Sinus rhythm at 30 days |
170 (94.4) |
178 (95.2) |
Sinus rhythm at 60 days |
170 (94.4) |
178 (95.2) |
AF for less than 48 hours |
106 (54.4) |
125 (63.5) |